The gene encoding the splicing factor SF2/ASF is a proto-oncogene

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Structural &Molecular Biology

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nsmb1209PMID 17310252PMCID PMC4595851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.

  2006cited by this paper
• Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

  2005cited by this paper
• Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.

  2005cited by this paper
• Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila.

  2005cited by this paper
• Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability.

  2005cited by this paper
• SRprises along a messenger's journey.

  2005cited by this paper
• ASF/SF2-Regulated CaMKII Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle

  2005cited by this paper
• Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities

  2004cited by this paper
• Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA.

  2004cited by this paper
• Expression of splicing factors in human ovarian cancer.

  2004cited by this paper
• An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis*

  2004cited by this paper
• Aberrant and Alternative Splicing in Cancer

  2004cited by this paper
• Alternative Splicing of the Multidrug Resistance Protein 1/ATP Binding Cassette Transporter Subfamily Gene in Ovarian Cancer Creates Functional Splice Variants and Is Associated with Increased Expression of the Splicing Factors PTB and SRp20

  2004cited by this paper
• A novel role for shuttling SR proteins in mRNA translation.

  2004cited by this paper
• Lost in translation: dysregulation of cap-dependent translation and cancer.

  2004cited by this paper
• Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines.

  2003cited by this paper
• Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences.

  2003cited by this paper
• Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays

  2003cited by this paper
• Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of c-Myb

  2003cited by this paper
• Specific SR protein-dependent splicing substrates identified through genomic SELEX.

  2003cited by this paper
• Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.

  2003cited by this paper
• The N and C Termini of the Splice Variants of the Human Mitogen-Activated Protein Kinase-Interacting Kinase Mnk2 Determine Activity and Localization

  2003cited by this paper
• The 17q23 Amplicon and Breast Cancer

  2003cited by this paper
• Alternative pre-mRNA splicing and regulation of programmed cell death.

  2003cited by this paper
• Mechanisms of alternative pre-messenger RNA splicing.

  2003cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Identification of a conserved motif required for mTOR signaling.

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Bin1 mediates apoptosis by c-Myc in transformed primary cells.

  2001cited by this paper
• Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation.

  2001cited by this paper
• Crystal structure of a Pumilio homology domain.

  2001cited by this paper
• p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

  2001cited by this paper
• Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor

  2001cited by this paper
• The Mitogen-Activated Protein Kinase Signal-Integrating Kinase Mnk2 Is a Eukaryotic Initiation Factor 4E Kinase with High Levels of Basal Activity in Mammalian Cells

  2001cited by this paper
• Methods for studying pro- and antiapoptotic genes in nonimmortal cells.

  2001cited by this paper
• SC35 plays a role in T cell development and alternative splicing of CD45.

  2001cited by this paper
• Expression of Brca1 and splice variant Brca1Δ11 RNA levels in mouse mammary gland during normal development and tumorigenesis

  2000cited by this paper
• Prospective Detection of Preclinical Lung Cancer : Results from Two Studies of Heterogeneous Nuclear Ribonucleoprotein A 2 / B 1 Overexpression

  2000cited by this paper
• Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.

  1999cited by this paper
• Phosphorylation of the Cap-Binding Protein Eukaryotic Translation Initiation Factor 4E by Protein Kinase Mnk1 In Vivo

  1999cited by this paper
• Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

  1999cited by this paper
• E1A signaling to p53 involves the p19(ARF) tumor suppressor.

  1998cited by this paper
• Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.

  1998cited by this paper
• A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm.

  1998cited by this paper
• Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.

  1997cited by this paper
• BIN1 is a novel MYC–interacting protein with features of a tumour suppressor

  1996cited by this paper
• The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

  1995cited by this paper
• A splice variant of alpha 6 integrin is associated with malignant conversion in mouse skin tumorigenesis.

  1995cited by this paper
• Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

  1994cited by this paper
• Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

  1992cited by this paper

• EcDNA-borne structural variants drive oncogenic fusion transcript amplification.

  2026cites this paper
• NCBP1 stress signaling drives alternative S6K1 splicing inhibiting translation.

  2026cites this paper
• Serine/arginine-rich splicing factor 1 inhibits ferroptosis and promotes glycolysis in endometrial cancer via activating mTOR and β-catenin.

  2026cites this paper
• Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding protein Sam68 in head and neck cancer.

  2026cites this paper
• The crosstalk between lung adenocarcinoma cells and M2 macrophages promotes cancer cell development via the SFRS1/miR-708-5p/PD-L1 axis.

  2025cites this paper
• IMPDH2 facilitates CD4+ T cell activation through AKT/mTOR pathway by upregulating SRPK1 in myasthenia gravis.

  2025cites this paper
• KATMAP infers splicing factor activity and regulatory targets from knockdown data.

  2025cites this paper
• Tumor-promoting effect and tumor immunity of SRSFs

  2025cites this paper
• SF3B1: from core splicing factor to oncogenic driver

  2025cites this paper
• The splicing factor SRRM2 modulates two S6K kinases to promote colorectal cancer growth

  2025cites this paper
• BRIX1 activated by mTORC1-SP1 signaling regulates ribosome biogenesis and alternative splicing to promote hepatocellular carcinoma progression

  2025cites this paper
• The oncogenic microRNA miR-222 promotes human LINE-1 retrotransposition

  2025cites this paper
• Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy

  2025cites this paper
• NUMB alternative splicing and isoform-specific functions in development and disease

  2025cites this paper
• Multidimensional regulatory roles and therapeutic applications of SRSF7 in cancer

  2025cites this paper
• Alternative Splicing at the Crossroad of Inflammatory Bowel Diseases and Colitis-Associated Colon Cancer

  2025cites this paper
• Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells

  2025cites this paper
• Transcriptomic analysis reveals lung cancer and subtype-specific alternative splicing biomarkers regulated by RNA-binding proteins

  2025cites this paper
• Identification of a CD138-negative therapy-resistant subpopulation in multiple myeloma with vulnerability to splicing factor inhibition.

  2025cites this paper
• EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAs

  2025cites this paper
• SRSF6 and SRSF1 coordinately enhance the inclusion of human MUSK exon 10 to generate a Wnt-sensitive MuSK isoform

  2025cites this paper
• Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in cervical precancerous lesions.

  2025cites this paper
• Nuclear ribonucleoprotein condensates as platforms for gene expression regulation

  2025cites this paper
• Elucidating the risk factors and oncogene drivers of acute myeloid leukemia

  2025cites this paper
• Revealing the role of U2AF1 in splicing regulation and chimeric RNA dynamics

  2025cites this paper
• SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression

  2025cites this paper
• SRSF3 undergoes phase separation in lung cancer and is associated with immunity and ferroptosis

  2025cites this paper
• CK1ε/SRSF10 axis regulates the alternative splicing of Bcl-x in lung cancer cells

  2025cites this paper
• GPATCH3, a splicing regulator that facilitates tumor immune evasion via the modulation of ATPase activity of DHX15

  2025cites this paper
• Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival.

  2025cites this paper
• Arginine demethylation of Serine/Arginine‐rich splicing factor 1 enhances miRNA enrichment in small extracellular vesicles derived from pancreatic ductal adenocarcinoma cells

  2025cites this paper
• Mutations in SR Subfamily Genes Affect Flowering Time and the Splicing of Multiple Floral Regulators including CO and FLC.

  2025cites this paper
• CircDiaph3 aggravates H/R-induced cardiomyocyte apoptosis and inflammation through miR-338-3p/SRSF1 axis

  2024cites this paper
• Proteomics Identifies LUC7L3 as a Prognostic Biomarker for Hepatocellular Carcinoma

  2024cites this paper
• Isoform switching regulates the response to ionizing radiation through SRSF1.

  2024cites this paper
• Protective effects of microalgal carotenoids against glycosylation-induced collagen degradation in skin

  2024cites this paper
• Glioblastoma vaccines: past, present, and opportunities

  2024cites this paper
• SRSF1, a Splicing-factor oncoprotein: Prospective biomarker and therapeutic target for oral cancer.

  2024cites this paper
• Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing

  2024cites this paper
• LTR Retrotransposon-Derived LncRNA LINC01446 Promotes Hepatocellular Carcinoma Progression and Angiogenesis by Regulating the SRPK2/SRSF1/VEGF Axis.

  2024cites this paper
• Dynamics of the splicing factor SRSF6 protein show metastable conformations with potentially druggable sites revealed by Markov state model

  2024cites this paper
• Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells

  2024cites this paper
• The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications

  2024cites this paper
• The Study of SRSF1 Regulates Abnormal Alternative Splicing of BCL2L11 and the Role in Refractory Acute Myeloid Leukemia

  2024cites this paper
• The FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export

  2024cites this paper
• Steering research on mRNA splicing in cancer towards clinical translation

  2024cites this paper
• Challenges in Therapeutically Targeting the RNA‐Recognition Motif

  2024cites this paper
• Best evidence linking the extracellular factor TGF-β to cancer-associated alternative splicing programs

  2024cites this paper
• Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment

  2024cites this paper
• Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer

  2024cites this paper
• The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells

  2024cites this paper
• Characterization of aberrant splicing in pediatric central nervous system tumors reveals CLK1 as a candidate oncogenic dependency

  2024cites this paper
• RBM25 depletion suppresses the growth of colon cancer cells through regulating alternative splicing of MNK2

  2024cites this paper
• Alternative Splicing Landscape of Head and Neck Squamous Cell Carcinoma

  2024influential citation
• Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia

  2024cites this paper
• RNA helicase D1PAS1 resolves R-loops and forms a complex for mouse pachytene piRNA biogenesis required for male fertility.

  2024cites this paper
• TIM22 and TIM29 inhibit HBV replication by up‐regulating SRSF1 expression

  2024cites this paper
• The new kids on the block: RNA‐binding proteins regulate autophagy in disease

  2024cites this paper
• Comprehensive analysis of splicing factor SRs-related gene characteristics: predicting osteosarcoma prognosis and immune regulation status

  2024cites this paper
• Interferon-Regulated Expression of Cellular Splicing Factors Modulates Multiple Levels of HIV-1 Gene Expression and Replication

  2024cites this paper
• Polyploidy and mTOR signaling: a possible molecular link

  2024cites this paper
• Identifying Possible Biomarkers for Early-Stage Hepatocellular Carcinoma using Random Forest Machine Learning Method

  2023cites this paper
• Rule-based prediction of diabetes mellitus using a classification based on association rules

  2023cites this paper
• The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations

  2023influential citation
• Molecular characteristics and clinical implications of serine/arginine-rich splicing factors in human cancer

  2023cites this paper
• Role of epithelial splicing regulatory protein 1 in cancer progression

  2023cites this paper
• The role of alternative pre-mRNA splicing in cancer progression

  2023cites this paper
• Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF‐mediated Bcl‐x exon 2b inclusion

  2023cites this paper
• Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics

  2023cites this paper
• Expression of Ribosomal Protein S6 Kinase (S6K1) Isoforms in Different Types of Papillary Thyroid Carcinoma

  2023cites this paper
• Citrullination and the protein code: crosstalk between post-translational modifications in cancer

  2023cites this paper
• Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis

  2023cites this paper
• Therapeutic Targeting of RNA Splicing in Cancer

  2023influential citation
• An intricate rewiring of cancer metabolism via alternative splicing.

  2023cites this paper
• SNORA73B promotes endometrial cancer progression through targeting MIB1 and regulating host gene RCC1 alternative splicing

  2023cites this paper
• Fine tuning of the transcription juggernaut: A sweet and sour saga of acetylation and ubiquitination.

  2023cites this paper
• Inhibition of nonsense-mediated mRNA decay may improve stop codon read-through therapy for Duchenne muscular dystrophy.

  2023cites this paper
• Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity

  2023cites this paper
• Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer.

  2023cites this paper
• The key role of microRNA-766 in the cancer development

  2023cites this paper
• SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability

  2023cites this paper
• Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)

  2023cites this paper
• Alternative mRNA Splicing and Promising Therapies in Cancer

  2023cites this paper
• Regulation of SUMOylation on RNA metabolism in cancers

  2023cites this paper
• Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer

  2023cites this paper
• RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer

  2023cites this paper
• Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death

  2023cites this paper
• Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis

  2023cites this paper
• Alternative splicing impacts microRNA regulation within coding regions

  2023cites this paper
• Oncogenic SRSF3 in health and diseases

  2023influential citation
• Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer

  2023cites this paper
• The Role of Splicing Factors in Adipogenesis and Thermogenesis

  2023cites this paper
• Towards understandings of serine/arginine-rich splicing factors

  2023cites this paper
• Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors

  2023cites this paper
• Splicing factor SNRPA associated with microvascular invasion promotes hepatocellular carcinoma metastasis through activating NOTCH1/Snail pathway and is mediated by circSEC62/miR‐625‐5p axis

  2023cites this paper
• SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer

  2023cites this paper
• New association between splicing factor‐coding gene polymorphisms and the risk of acute lymphoblastic leukemia in southern Chinese children: A five‐center case–control study

  2023cites this paper
• Targeting splicing factors for cancer therapy

  2023cites this paper
• Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

  2023cites this paper